Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US5955357

Title:In-vitro-derived human neutrophil precursor cells
Inventors:Bender, James G.; Lindenhurst, IL, USA
Maples, Phillip B.; Waukegan, IL, USA
Smith, Stephen L.; Arlington Heights, IL, USA
Unverzagt, Kristen L.; Palatine, IL, USA
Van Epps, Dennis E.; Cary, IL, USA
Summary:This invention describes a composition of human neutrophil precursor cells consisting of at least 37% myeloblasts and promyeloblasts, and free of bound monoclonal antibodies. Further disclosed are properties of hematopoietic cell suspensions which contain human neutrophil precursor cells and at least one hematopoietic growth factor. Therapeutic applications are described, such as in the treatment of neutropenia that has been induced by high dose chemotherapy.
Abstract:The present invention provides a composition of human neutrophil precursor cells having at least 37% myeloblasts and promyeloblasts. Also provided are hematopoietic cell suspensions that have human neutrophil precursor cells and at least one hematopoietic growth factor.
US Patent Website:Click Here for Full Text of Patent
Title Number:US5955357
Application Number:US1994000295501
Date Filed:23/08/1994
Date Published:21/09/1999
Assignee:Nexell Therapeutics Inc., Irvine, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/13/2021